Results 211 to 220 of about 325,649 (265)

Accuracy of Accuhaler, Ellipta, and Turbuhaler Testers in Patients with Chronic Obstructive Pulmonary Disease. [PDF]

Med Sci (Basel)
Saiphoklang N, Siriyothipun T, Panichaporn S.   +2 more
europepmc   +1 more source

Trends in gabapentinoid prescribing: A nationwide Danish drug utilization study

British Journal of Clinical Pharmacology, EarlyView.
Aims Pregabalin and gabapentin are increasingly used for pain and other conditions. Concerns exist about overuse as well as potential misuse and abuse. To guide rational prescribing practices, we provide detailed nationwide data on the use of gabapentinoids in Denmark.
Anton Pottegård, Lotte Rasmussen, Morten Olesen, Anne Mette Skov Sørensen, Zandra Nymand Ennis, Joseph Kane, Sarah Baxter, Blánaid Hicks   +7 more
wiley   +1 more source

Comparison of stability of the GOLD and STAR lung function classification for chronic obstructive pulmonary disease. [PDF]

BMJ Open Respir Res
Tsai IL, Ting-Chia C, Huang TH, Chang-Wen C, Hsiue TR, Tsung Y, Kuo CW.   +6 more
europepmc   +1 more source

Real‐world population pharmacokinetics of tezacaftor‐ivacaftor in children with cystic fibrosis: The SYM‐CF study

British Journal of Clinical Pharmacology, EarlyView.
Aims The clinical effectiveness of tezacaftor‐ivacaftor in children with cystic fibrosis (cwCF) varies; some patients respond while others do not or have adverse effects. The pharmacokinetics (PK) of tezacaftor‐ivacaftor are inadequately published, especially in children.
Steffie E. M. Vonk, Suzanne W. J. Terheggen‐Lagro, Eric G. Haarman, Hettie M. Janssens, Anke‐Hilse Maitland–van der Zee, E. Marleen Kemper, Ron A. A. Mathôt, on behalf of the Amsterdam Mucociliary Clearance Disease (AMCD) research group   +7 more
wiley   +1 more source

Impact of socioeconomic status on chronic obstructive pulmonary disease prognosis: a national cohort study. [PDF]

Front Med (Lausanne)
Lee H, Jung J, Yoon HY.
europepmc   +1 more source

Effect of Respiratory Rate on Respiratory Patterns in Patients with Chronic Obstructive Pulmonary Disease.

, 1997
Masakí Inoue, Toshiaki Homma, Hiromichi Aoki, Masaaki Sumi, Itaru Ohtsu, S Tomioka, Masaaki Hagiya, Yūko Yamashita, Shizuo Hasegawa   +8 more
openalex   +2 more sources

Establishing a 3D Vascularized Tri‐Culture Model of the Human Airways via a Digital Light Processing Bioprinter

Biotechnology and Bioengineering, EarlyView.
ABSTRACT The rise in chronic lung diseases globally and the corresponding lag in drug discovery in this field highlights the need for In Vitro models closely mimicking In Vivo lung tissue. Efforts to date have largely focused on In Vitro coculture models, often neglecting the pulmonary vasculature's role in lung physiology and lacking perfusability. To
Sakshi Phogat, Tony Ju Feng Guo, Fama Thiam, Emmanuel Twumasi Osei   +3 more
wiley   +1 more source

The Effect of Fluticasone Nasal Spray on Patients with Chronic Rhinitis and Chronic Obstructive Pulmonary Disease. [PDF]

J Clin Med
Dai ZY, Li YT, Lin JY, Liu CL, Tsou YA, Lin CD, Tai CJ, Shih LC.   +7 more
europepmc   +1 more source

Lung Volumes in Smokers without Chronic Obstructive Pulmonary Disease: A Pointer to Disease Development? [PDF]

Ann Am Thorac Soc
Calverley PMA.
europepmc   +1 more source

Unveiling the complexity of cellular senescence in cancers: From mechanism to therapeutic opportunities

BMEMat, EarlyView.
This review highlights the complex roles of cellular senescence in cancer progression and suppression, discusses the mechanisms and regulatory pathways involved, and evaluates the efficacy of the “One‐Two punch” sequential treatment approach while addressing emerging challenges in this novel therapeutic strategy.
Qiuming Pan, Ye Zhu, Zhi Ye, Huayang Zhang, Junxi Wang, Guozhong Yi, Zhiyong Li, Rongyang Xu, Luyao Wang, Zhenzhen Wu, Songtao Qi, Guanglong Huang, Shanqiang Qu   +12 more
wiley   +1 more source